Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Shares Outstanding (Weighted Average) (2022 - 2025)

Core Laboratories' Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $46.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 1.0% year-over-year to $46.4 million; the TTM value through Dec 2025 reached $46.4 million, down 1.0%, while the annual FY2025 figure was $46.4 million, 1.0% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $46.4 million in Q4 2025 per CLB's latest filing, roughly flat from $46.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.9 million in Q3 2024 to a low of $46.3 million in Q2 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $46.6 million, with a median of $46.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.81% in 2023, then dropped 1.0% in 2025.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $46.3 million in 2022, then increased by 0.75% to $46.7 million in 2023, then increased by 0.46% to $46.9 million in 2024, then fell by 1.0% to $46.4 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Shares Outstanding (Weighted Average) are $46.4 million (Q4 2025), $46.6 million (Q3 2025), and $46.7 million (Q2 2025).